Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Almut G Winterstein

Showing results (241-250 of 266) with videos related to

Pageof 27
Sort By:
Drug Safety|April 17, 2026
Risk of Fetal Exposure to Teratogenic Medications: Development of Evidence for the Teratogenic Risk Impact and Mitigation (TRIM) ToolYanning Wang, Celeste L Y Ewig, Nicole E Smolinski, et al.
Journal of the American Medical Informatics Association : JAMIA|May 13, 2023
Developing and validating a natural language processing algorithm to extract preoperative cannabis use status documentation from unstructured narrative clinical notesRuba Sajdeya, Mamoun T Mardini, Patrick J Tighe, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 7, 2020
Machine Learning in Drug Discovery and Development Part 1: A PrimerAlan Talevi, Juan Francisco Morales, Gregory Hather, et al.
Pharmacoepidemiology and Drug Safety|January 8, 2014
RE: Drug risk assessment and data reuseSengwee Toh, Jerry Avorn, Ralph B D'Agostino, et al.
Pharmacoepidemiology and Drug Safety|August 8, 2013
Re-using Mini-Sentinel data following rapid assessments of potential safety signals via modular analytic programsSengwee Toh, Jerry Avorn, Ralph B D'Agostino, et al.
Journal of Substance Abuse Treatment|March 11, 2016
Utilization of Alcohol Treatment Among HIV-Positive Women with Hazardous DrinkingXingdi Hu, Jeffrey Harman, Almut G Winterstein, et al.
Drug Safety|November 5, 2024
Teratogenic Risk Impact and Mitigation (TRIM): Study Protocol for the Development of a Decision Support Tool to Prioritize Medications for Risk MitigationAlmut G Winterstein, Celeste L Y Ewig, Yanning Wang, et al.
Medical Cannabis and Cannabinoids|October 22, 2021
A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019Sebastian Jugl, Aimalohi Okpeku, Brianna Costales, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 8, 2009
Prophylactic nesiritide does not prevent dialysis or all-cause mortality in patients undergoing high-risk cardiac surgeryA Ahsan Ejaz, Tomas D Martin, Richard J Johnson, et al.
Atherosclerosis|July 25, 2013
Associations between aspirin and other non-steroidal anti-inflammatory drugs and aortic valve or coronary artery calcification: the Multi-Ethnic Study of Atherosclerosis and the Heinz Nixdorf Recall StudyJoseph A Delaney, Nils Lehmann, Karl-Heinz Jöckel, et al.
Pageof 27

Showing results (241-250 of 266) with videos related to

Sort By:
Pageof 27
Drug Safety|April 17, 2026
Risk of Fetal Exposure to Teratogenic Medications: Development of Evidence for the Teratogenic Risk Impact and Mitigation (TRIM) ToolYanning Wang, Celeste L Y Ewig, Nicole E Smolinski, et al.
Journal of the American Medical Informatics Association : JAMIA|May 13, 2023
Developing and validating a natural language processing algorithm to extract preoperative cannabis use status documentation from unstructured narrative clinical notesRuba Sajdeya, Mamoun T Mardini, Patrick J Tighe, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 7, 2020
Machine Learning in Drug Discovery and Development Part 1: A PrimerAlan Talevi, Juan Francisco Morales, Gregory Hather, et al.
Pharmacoepidemiology and Drug Safety|January 8, 2014
RE: Drug risk assessment and data reuseSengwee Toh, Jerry Avorn, Ralph B D'Agostino, et al.
Pharmacoepidemiology and Drug Safety|August 8, 2013
Re-using Mini-Sentinel data following rapid assessments of potential safety signals via modular analytic programsSengwee Toh, Jerry Avorn, Ralph B D'Agostino, et al.
Journal of Substance Abuse Treatment|March 11, 2016
Utilization of Alcohol Treatment Among HIV-Positive Women with Hazardous DrinkingXingdi Hu, Jeffrey Harman, Almut G Winterstein, et al.
Drug Safety|November 5, 2024
Teratogenic Risk Impact and Mitigation (TRIM): Study Protocol for the Development of a Decision Support Tool to Prioritize Medications for Risk MitigationAlmut G Winterstein, Celeste L Y Ewig, Yanning Wang, et al.
Medical Cannabis and Cannabinoids|October 22, 2021
A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019Sebastian Jugl, Aimalohi Okpeku, Brianna Costales, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 8, 2009
Prophylactic nesiritide does not prevent dialysis or all-cause mortality in patients undergoing high-risk cardiac surgeryA Ahsan Ejaz, Tomas D Martin, Richard J Johnson, et al.
Atherosclerosis|July 25, 2013
Associations between aspirin and other non-steroidal anti-inflammatory drugs and aortic valve or coronary artery calcification: the Multi-Ethnic Study of Atherosclerosis and the Heinz Nixdorf Recall StudyJoseph A Delaney, Nils Lehmann, Karl-Heinz Jöckel, et al.
Pageof 27